Kancer Ltd Kancer will be focussed on the development of new products based upon the reformulation of existing approved therapies and breakthrough treatments for cancer. Our strategic aim is that:“Kancer will develop unique targetted therapies that can improve the prognosis for patients using our delivery systems and in some cases specifically target a patient’s own cancer cells” Website: www.kancer.co.uk Key Projects Kancer’s prospective projects represent a balance of risk and technologies designed to increase the opportunity to make an impact on this disease: Individualised therapy for multiple myeloma Oral GCSF (GMCSF) – white blood cell rebuilder Oral Interferon Inducing Apoptosis – using Special Targetting amino acid construct Possible Cancer Vaccines